Shares of Cigna (NYSE: CI) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% earlier in the day. The leg down comes as the S&P 500 gained 0.2% and the Nasdaq Composite lost 0.2%.
The insurer reported earnings before the market open, missing certain estimates and offering guidance that disappointed investors.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »
While Cigna's Q4 revenue of $65.65 billion beat Wall Street's estimate of $63.44, rising medical costs led to a much more significant earnings-per-share (EPS) miss. The company delivered $6.64 per share, when Wall Street expected $7.82.
Health insurance companies use a key metric called the medical cost ratio to track the relationship between premiums and expenses paid -- lower is better. Cigna reported a ratio of 87.9%, higher than the expected 84.7%.
Cigna CEO David Cordani said in the earnings call Cigna is taking "corrective actions to address these near-term pressures" and "steps to further advance our long-term growth strategy" in the face of these rising costs. During the call, the team told investors that it would take two years to recover the margins compacted by higher-than-expected costs. In light of this, the company forecasts EPS for 2025 to hit $29.50 while Wall Street has expected guidance of $31.50 per share.
In good news for shareholders, the board of directors increased Cigna's quarterly dividend by 8% and authorized a $6 billion increase in share repurchasing.
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.
Learn more »
*Stock Advisor returns as of January 27, 2025
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.